Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marta Martin Richard, MD
Grupo Espanol Multidisciplinario del Cancer Digestivo
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Clinic de Barcelona
Barcelona, Spain
- Hospital Sant Pau
Barcelona, Spain
- H. Josep Trueta
Girona, Spain
- Centro Oncológico M.D. Anderson Spain
Madrid, Spain
- Hospital la Paz
Madrid, Spain
- Hospital de Fuenlabrada
Madrid, Spain
- Hospital Althaia
Manresa, Spain
- Clínica Universitaria de Navarra
Pamplona, Spain
- Hospital Parc Taulí
Sabadell, Spain
- Hospital General de Valencia
Valencia, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2008
- Primary completion
- 31 Oct 2011
- Completion
- 31 Dec 2011
- Last update posted
- 9 Nov 2012
- Registered enrollment
- 41
- Registry id
- NCT01262482
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.